BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27150367)

  • 1. Medicinal Attributes of Imidazo[1,2-a]pyridine Derivatives: An Update.
    Devi N; Singh D; Rawal RK; Bariwal J; Singh V
    Curr Top Med Chem; 2016; 16(26):2963-2994. PubMed ID: 27150367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the pharmacology of imidazo[1,2-a]pyridines.
    Enguehard-Gueiffier C; Gueiffier A
    Mini Rev Med Chem; 2007 Sep; 7(9):888-99. PubMed ID: 17897079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.
    Krause M; Foks H; Gobis K
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents.
    Deep A; Bhatia RK; Kaur R; Kumar S; Jain UK; Singh H; Batra S; Kaushik D; Deb PK
    Curr Top Med Chem; 2017; 17(2):238-250. PubMed ID: 27237332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
    Castera-Ducros C; Paloque L; Verhaeghe P; Casanova M; Cantelli C; Hutter S; Tanguy F; Laget M; Remusat V; Cohen A; Crozet MD; Rathelot P; Azas N; Vanelle P
    Bioorg Med Chem; 2013 Nov; 21(22):7155-64. PubMed ID: 24080103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic Synthesis of Indole-Based Imidazopyridine using α-Amylase.
    Kamboj P; Tyagi V
    Chembiochem; 2024 Mar; 25(6):e202300824. PubMed ID: 38279707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridines and Imidazopyridines with Medicinal Significance.
    Kishbaugh TL
    Curr Top Med Chem; 2016; 16(28):3274-3302. PubMed ID: 27150370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
    Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H
    Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
    Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and SAR of Novel and Selective Inhibitors of Urokinase Plasminogen Activator (uPA) with an Imidazo[1,2-a]pyridine Scaffold.
    Gladysz R; Adriaenssens Y; De Winter H; Joossens J; Lambeir AM; Augustyns K; Van der Veken P
    J Med Chem; 2015 Dec; 58(23):9238-57. PubMed ID: 26575094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.
    Li L; Li Z; Liu M; Shen W; Wang B; Guo H; Lu Y
    Molecules; 2015 Dec; 21(1):E49. PubMed ID: 26729085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazo[4,5-
    Jarmoni K; Misbahi K; Ferrières V
    Curr Med Chem; 2024; 31(5):515-528. PubMed ID: 37170991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
    Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.
    Garrido A; Vera G; Delaye PO; Enguehard-Gueiffier C
    Eur J Med Chem; 2021 Dec; 226():113867. PubMed ID: 34607244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Access to Imidazo[1,2- a]pyridines/pyrazines/pyrimidines via Catalyst-Free Annulation Reaction under Microwave Irradiation in Green Solvent.
    Rao RN; Mm B; Maiti B; Thakuria R; Chanda K
    ACS Comb Sci; 2018 Mar; 20(3):164-171. PubMed ID: 29373013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances.
    Khatun S; Singh A; Bader GN; Sofi FA
    J Biomol Struct Dyn; 2022; 40(24):14279-14302. PubMed ID: 34779710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy.
    Goel R; Luxami V; Paul K
    Curr Top Med Chem; 2016; 16(30):3590-3616. PubMed ID: 27086790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile synthesis, structural evaluation, antimicrobial activity and synergistic effects of novel imidazo[1,2-a]pyridine based organoselenium compounds.
    Kumar S; Sharma N; Maurya IK; Bhasin AKK; Wangoo N; Brandão P; Félix V; Bhasin KK; Sharma RK
    Eur J Med Chem; 2016 Nov; 123():916-924. PubMed ID: 27565415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
    Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.